Novo Nordisk A/S (NVO) Stock Price Today
Aura AI Summary
Key Stats
- $215.77BMarket Cap
- -Volume
- HealthSector
- $71.7052W High
- $35.2952W Low
- -Typical Hold Time
- $234.75BEnterprise Value
- 3.69%Div Yield
- -Trading Activity
Track Novo Nordisk A/S (NVO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Novo Nordisk A/S has traded between a low of $35.29 and a high of $71.7, highlighting its annual price range. Buy and sell Novo Nordisk A/S shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Most Recent News
Eneba becomes official global distributor of NetEase Pay gift cards for popular games like Marvel Rivals.
Eneba, a fast-growing digital entertainment marketplace, has partnered with NetEase Games to become an official distributor of NetEase Pay gift cards worldwide. This allows users to buy gift cards in various USD denominations with instant delivery, r...

Class action lawsuits filed against AVAV, CALX, ZTS, and LCID for misleading investors, deadlines approaching.
The Law Offices of Frank R. Cruz announced class action lawsuits against AeroVironment (AVAV), Calix (CALX), Zoetis (ZTS), and Lucid Group (LCID) for allegedly making false or misleading statements and withholding material adverse information about t...

State Street Global Advisors increases stake in DCC plc to 1.42% after recent share purchases.
State Street Global Advisors & Affiliates disclosed an increase in their holding of DCC plc shares to 1.42%, following recent purchases of 338 shares at €62.85 each and sales of 96 shares at the same price. This disclosure is part of regulatory requi...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.